...
首页> 外文期刊>Der Pharmacia Lettre >In silico structural analysis of Hantaan virus glycoprotein G2 and conserved epitope prediction for vaccine development
【24h】

In silico structural analysis of Hantaan virus glycoprotein G2 and conserved epitope prediction for vaccine development

机译:汉坦病毒糖蛋白G2的计算机计算机结构分析和保守的表位预测,用于疫苗开发

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Hantaan virus (HNTV), a prototypic member of Hantavirus genus, is an etiological agent of potentially fatal hemorrhagic fever with renal syndrome (HFRS). The virus infects a large number of patients annually, with a mortality rate more than 10%. However, no treatment option or vaccine is available against the virus. The virus expresses two envelope proteins having role in viral attachment to host. Among them HNTV glycoprotein G2 has higher antigenicity making it a better target for vaccine development. However, 3-D structure of the protein is not available which is important for identifying epitopes that are essential for vaccine design. Therefore, this study was designed to predict a structural model of glycoprotein G2 and to predict peptide sequences for vaccine development containing conserved epitopes within the structure. Many of the physio-chemical and structural properties including secondary structure and di-sulfide linkage of the protein were predicted using a number of computational tools. The 3D structure of the protein was modeled using I-TASSER online tool. The quality of the predicted models was evaluated with Ramachandran plot and Z-score. The structural and sequence information was used to predict B-cell and T-cell epitopes on glycoprotein G2. A model with reliable quality was generated. Using various bio-informatics and immuno-informatics tools, a total of 9 continuous B-cell and 22 T-cell epitopes were predicted having significant antigenicity. These antigenic epitopes were further analyzed for conservation and a total of 4 B-cells and 8 T-cell epitopes were found to be highly conserved in sequences from diverse origins. These epitopes revealed by the current study are recognized by immune system to protect host from HNTV infection can be potential targets for vaccine development.
机译:汉坦病毒属的原型成员汉坦病毒(HNTV)是潜在的致命性肾综合征出血热(HFRS)的病原体。该病毒每年感染大量患者,死亡率超过10%。但是,没有针对该病毒的治疗选择或疫苗。该病毒表达两种包膜蛋白,它们在病毒与宿主的附着中起作用。其中HNTV糖蛋白G2具有更高的抗原性,使其成为疫苗开发的较好靶标。但是,蛋白质的3-D结构不可用,这对于鉴定疫苗设计必不可少的表位很重要。因此,本研究旨在预测糖蛋白G2的结构模型,并预测用于疫苗开发的肽序列,该肽序列在结构内包含保守的表位。使用许多计算工具可以预测蛋白质的许多物理化学和结构特性,包括蛋白质的二级结构和二硫键。使用I-TASSER在线工具对蛋白质的3D结构进行建模。预测模型的质量通过Ramachandran图和Z评分进行评估。结构和序列信息用于预测糖蛋白G2上的B细胞和T细胞表位。生成了质量可靠的模型。使用各种生物信息学和免疫信息学工具,预计总共9个连续B细胞表位和22个T细胞表位具有显着的抗原性。进一步分析了这些抗原表位的保守性,发现总共4个B细胞表位和8个T细胞表位在来自不同来源的序列中高度保守。当前研究揭示的这些表位已被免疫系统识别,可以保护宿主免受HNTV感染,这可能是疫苗开发的潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号